Genetic susceptibility to vaginal candidiasis

References

• Hilton E, Chandrasekaran V, Rindos P, et al. Association of recurrent candidal vaginitis with inheritance of Lewis blood group antigens. J Infect Dis 1995; 172: 1616–1619.
   PubMed Web of Science ®Google Scholar
• Hanson LH, Perlman AM, Clemons KV, et al. Synergy between cilofungin and amphotericin B in a murine model of candidiasis. Antimicrob Agents Chemother 1991; 35: 1334–1337.
   PubMed Web of Science ®Google Scholar
• Clemons KV, Stevens DA. Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combina-tion with recombinant granulocyte colony-stimulating factor or interferon-y. Med Mycol 2000; 38: 213–219.
   PubMed Web of Science ®Google Scholar
• Sorensen KN, Wanstrom AA, Allen SD, et al. Efficacy of syringomycin E in a murine model of vaginal candidiasis. J Antibiotics 1998; 51: 743–749.
   PubMed Web of Science ®Google Scholar
• Ryley JF, McGregor S. Quantification of vaginal Candida albicans infections in rodents. J Med Vet Mycol 1986; 2: 455–460.
   Google Scholar
• Sokal RR, Rohlf FJ. Biometry, 2nd edn. San Francisco: W.H. Freeman, 1981.
   Google Scholar
• Stevens DA, Calderon L, Martinez M, et al. Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model. J Antimicrob Chemother 2002; 50: 361–364.
   Google Scholar
• Rhodes JC, Wicker LS, Urba WJ. Genetic control of suscept-ibility to Cryptococcus in mice. Infect Immun 1990; 29: 494–499.
   Google Scholar
• Hector RF, Yee E, Collins MS. Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillo-sis. Infect Immun 1990; 58: 1476–1478.
   Google Scholar
• Byron JK, Clemons KV, McCusker JH, et al. Pathogenicity of Saccharomyces cerevisiae in complement factor five (C5) deficient mice. Infect Immun 1995; 63: 478–485.
   PubMedGoogle Scholar
• Diez-Orejas R, Molero G, Navarro-Garcia F, et al. Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen activated protein kinase in pathogenesis. Infect Immun 1997; 65: 833–837.
   Google Scholar
• Morozumi PA, Halpern JW, Stevens DA. Susceptibility differences of inbred strains of mice to blastomycosis. Infect Immun 1981; 32: 160–168.
   Google Scholar
• Morozumi PA, Brummer E, Stevens DA. Strain differences in resistance to infection reversed by route of challenge: studies in blastomycosis. Infect Immun 1981; 34: 623–625.
   Google Scholar
• Bistoni F, Marconi P, Frati L, et al. Increase of mouse resistance to Candida albicans infection by thymosin alpha-1. Infect Immun 1982; 36: 609–614.
   Google Scholar
• Hector RF, Domer JE, Carrow EW. Immune responses to Candida albicans in genetically distinct mice. Infect Immun 1982; 38: 1020–1028.
   PubMed Web of Science ®Google Scholar
• Ashman RB, Fulurija A, Papadimitriou JM. Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load. Infect Immun 1996; 64: 1866–1869.
   Google Scholar
• Londono P, Gao XM, Bowe F, et al. Evaluation of the intranasal challenge route in mice as a mucosal model for Candida albicans infection. Microbiology 1988; 144: 2291–2298.
   Google Scholar
• Fidel PL, Cutright JL, Sobel JD. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections. Infect Immun 1995; 63: 4191–4194.
   Google Scholar
• Black CA, Eyers FM, Dunkley ML, et al. Major histocompat-ibility haplotype does not impact the course of experimentally induced murine vaginal candidiasis. Lab Animal Sci 1999; 49: 668–672. © 2003 SHAM, Medical Mycology, 41, 143-147
   Google Scholar
• Mulero-Marchese RD, Blank KJ, Sieck TG. Genetic basis for protection against experimental vaginal candidiasis by periph-eral immunization. J Infect Dis 1998; 178: 227–234.
   Google Scholar
• Mulero-Marchese RD, Blank KJ, Sieck TO. Strain-dependent migration of lymphocytes to the vaginal mucosa after peripheral immunization. Immunogenetics 1999; 49: 973–980.
   Google Scholar
• Brummer E, Stevens DA. Anticryptococcal activity of macro-phages: role of C5 sufficient serum, phagocytosis, mouse strain, L-arginine, and effect of fluconazole. Cell Immunol1994; 157: 1–10.
   Google Scholar
• Brummer E., Gilmore GL, Shadduck RK, et al. Development of macrophage anticryptococcal activity in vitro is dependent on endogenous M-CSF. Cell Immunol 1998; 189: 144–148.
   Google Scholar
• Spearow JL, Doemeny P, Sera R, et al. Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science 1999; 285: 1259–1261.
   PubMed Web of Science ®Google Scholar